Sangamo Therapeutics Inc (NASDAQ:SGMO)

23.30
Delayed Data
As of Feb 16
 +0.30 / +1.30%
Today’s Change
3.65
Today|||52-Week Range
23.75
+42.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues24.1M45.9M39.5M19.4M
 
 
 
 
 
Depreciation And Amortization569.0K549.0K988.0K997.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.1M71.9M85.3M91.0M
 
 
 
 
 
Research And Development37.0M56.7M67.1M65.6M
 
 
 
 
 
Total Operating Expenses50.7M72.4M86.3M91.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.5M-26.6M-46.8M-72.6M
 
 
 
 
 
Extraordinary Credit0.000.001.8M0.00
 
 
Extraordinary Charge-160.0K-230.0K-1.9M0.00
 
 
 
 
Other Expenses0.000.00431.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.6M-26.4M-46.4M-71.7M
 
 
 
 
 
Income Taxes0.000.00-5.7M-14.0K
 
 
 
Net Income-26.6M-26.4M-40.7M-71.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.0M67.0M69.8M70.6M
 
 
 
 
 
Shares To Calculate EPS Diluted56.0M67.0M69.8M70.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.39-$0.58-$1.02
 
 
 
 
 
EPS Diluted-$0.48-$0.39-$0.58-$1.02